Pahayahay, Novie .
HRN: 20-11-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/03/2023
IV
1.5gram
Q 8hrs
S/P Cesarean Section
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes